Wolverine Trading’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.16M Sell
43,819
-20,276
-32% -$538K ﹤0.01% 369
2025
Q1
$1.64M Buy
64,095
+16,327
+34% +$419K ﹤0.01% 262
2024
Q4
$1.9M Sell
47,768
-7,743
-14% -$308K ﹤0.01% 367
2024
Q3
$3.42M Buy
55,511
+37,462
+208% +$2.31M ﹤0.01% 124
2024
Q2
$957K Sell
18,049
-2,925
-14% -$155K ﹤0.01% 418
2024
Q1
$1.72M Buy
20,974
+9,788
+88% +$803K ﹤0.01% 269
2023
Q4
$208K Sell
11,186
-28,237
-72% -$525K ﹤0.01% 1039
2023
Q3
$436K Sell
39,423
-112,383
-74% -$1.24M ﹤0.01% 633
2023
Q2
$2.37M Sell
151,806
-12,457
-8% -$195K ﹤0.01% 192
2023
Q1
$2.85M Buy
164,263
+128,120
+354% +$2.22M ﹤0.01% 144
2022
Q4
$340K Buy
+36,143
New +$340K ﹤0.01% 571
2022
Q3
Hold
0
2297
2022
Q2
Hold
0
2383
2022
Q1
Sell
-16,250
Closed -$75K 2630
2021
Q4
$75K Buy
+16,250
New +$75K ﹤0.01% 1497
2021
Q3
Hold
0
2737
2021
Q2
Hold
0
2655
2021
Q1
Hold
0
2536
2020
Q4
Hold
0
2204
2020
Q3
Hold
0
2054
2020
Q2
Sell
-30,615
Closed -$145K 2075
2020
Q1
$145K Buy
+30,615
New +$145K ﹤0.01% 1040
2019
Q4
Hold
0
2044
2019
Q3
Hold
0
1998
2019
Q1
Sell
-41,774
Closed -$316K 2076
2018
Q4
$316K Sell
41,774
-26,436
-39% -$200K ﹤0.01% 829
2018
Q3
$1.19M Buy
+68,210
New +$1.19M ﹤0.01% 463